Lorlatinib usage and dosage

Lorlatinib is a new generation of targeted drugs mainly used to treat non-small cell lung cancer (NSCLC) with mutations in ALK (tyrosine kinase) and ROS1 (kinase). Patients need to strictly follow their doctor's recommendations when using lorlatinib and follow professional medication guidance to ensure safe and effective treatment. The following is the detailed usage and dosage instructions of lorlatinib:

1. Drug characteristics: Lorlatinib is an oral preparation, usually in the form of tablets or capsules for patients. Each tablet or capsule contains a specific dose of lorlatinib, which is based on the patient's specific condition and the advice of their doctor.

2. Individualization of dose: Recommended dose100mgOnce daily. The dose of lorlatinib is usually determined based on multiple considerations including the patient's weight, liver function, disease characteristics, and previous treatment experience. The doctor will develop a personalized treatment plan based on the patient's individual situation to ensure that the patient gets the best results.

3. General Recommendations: Generally, the generally recommended dose of lorlatinib is one oral dose per day. Patients should read and understand the drug instructions before each medication, and take it strictly in accordance with the doctor's recommendations. At the same time, it is recommended to take it within a certain period of time before or after meals to improve the absorption effect of the drug.

4. Effects before or after meals: The usage of lorlatinib is usually recommended within a certain period of time before or after meals. Patients should seek specific dietary advice from their physician before taking the medication to ensure optimal absorption of the medication and reduce possible gastrointestinal discomfort.

5. Dose adjustment: During treatment, the doctor may make dosage adjustments based on the patient's specific condition and the efficacy of the drug. This may involve increasing or decreasing the daily dose to ensure treatment while minimizing the occurrence of side effects.

6. Regular monitoring: Patients need to undergo regular monitoring and examinations during medication, including blood tests, imaging examinations, etc., to evaluate disease response and monitor potential adverse reactions. This helps doctors adjust treatment plans in a timely manner to ensure the best treatment results.

7. Interactions with other drugs: Patients should inform their physician of all medications they are taking while taking lorlatinib, including prescription drugs, over-the-counter drugs, and supplements. Some drugs may interact with lorlatinib, affecting its efficacy or increasing the risk of side effects.

8. Management of side effects: Lorlatinib may cause some side effects, including but not limited to nausea, fatigue, headache, etc. Patients should promptly report any symptoms of discomfort to their physician so that the physician can take appropriate measures, which may include adjusting the dosage or providing supportive care.

9. Continuity of medication: Patients should continue to use lorlatinib in accordance with the doctor's recommendations and prescriptions until the doctor directs the discontinuation of the drug. Stopping medication or adjusting the dose midway may affect the efficacy of the drug, so patients should actively follow the doctor's instructions and maintain the continuity of medication.

Close collaboration between the patient and the healthcare team is critical while using lorlatinib. Regular follow-up, monitoring and communication help ensure patients receive the best possible results from their treatment and minimize potential risks. Any concerns or questions about medication should be communicated to the doctor promptly to ensure that the patient's medication experience is safe, effective, and good.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. Please consult the local hospital pharmacy for details. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.